QSI vs. DCGO, FARO, ORGN, GEOS, SLAM, VLN, MG, TRUE, WBX, and DOMO Should you be buying Quantum-Si stock or one of its competitors? The main competitors of Quantum-Si include DocGo (DCGO), FARO Technologies (FARO), Origin Materials (ORGN), Geospace Technologies (GEOS), Slam (SLAM), Valens Semiconductor (VLN), Mistras Group (MG), TrueCar (TRUE), Wallbox (WBX), and Domo (DOMO).
DocGo (NASDAQ:DCGO ) and Quantum-Si (NASDAQ:QSI ) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.
DocGo has a net margin of 2.98% compared to DocGo's net margin of -7,145.76%. Quantum-Si's return on equity of 6.20% beat DocGo's return on equity.
DocGo has a beta of 0.96, meaning that its stock price is 4% less volatile than the S&P 500. Comparatively, Quantum-Si has a beta of 3.04, meaning that its stock price is 204% more volatile than the S&P 500.
In the previous week, DocGo had 7 more articles in the media than Quantum-Si. MarketBeat recorded 11 mentions for DocGo and 4 mentions for Quantum-Si. DocGo's average media sentiment score of 0.70 beat Quantum-Si's score of 0.65 indicating that Quantum-Si is being referred to more favorably in the news media.
DocGo has higher revenue and earnings than Quantum-Si. Quantum-Si is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks.
DocGo currently has a consensus price target of $7.75, indicating a potential upside of 151.62%. Quantum-Si has a consensus price target of $2.67, indicating a potential upside of 48.15%. Given Quantum-Si's stronger consensus rating and higher possible upside, equities analysts clearly believe DocGo is more favorable than Quantum-Si.
DocGo received 37 more outperform votes than Quantum-Si when rated by MarketBeat users. Likewise, 73.21% of users gave DocGo an outperform vote while only 66.67% of users gave Quantum-Si an outperform vote.
56.4% of DocGo shares are owned by institutional investors. Comparatively, 39.9% of Quantum-Si shares are owned by institutional investors. 13.8% of DocGo shares are owned by company insiders. Comparatively, 30.0% of Quantum-Si shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary DocGo beats Quantum-Si on 14 of the 18 factors compared between the two stocks.
This chart shows the number of new MarketBeat users adding QSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Quantum-Si Competitors List
Related Companies and Tools
